OS2.1 Immune responses to a mutation-specific peptide vaccine targeting IDH1R132H in patients with IDH1R132H-mutated gliomas

Immunotherapeutic concepts for brain tumors have been hampered by lack of selective measures to target the CNS and lack of truly tumor-specific antigens. But the concept of an immune privileged CNS has to be questioned due to survey of the brain by specific T-cells, CNS autoimmunity and presence of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Bunse, T., Bunse, L., Sahm, F., Omokoko, T., Stevanovic, S., Deimling, A. von, Sahin, U., Schmitt, M., Wick, W., Platten, M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2016
Konular:
OS2 Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5782511/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.011
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller